Diuretic therapy and resistance in congestive heart failure

Research output: Contribution to journalArticle

205 Citations (Scopus)

Abstract

Treatment of congestive heart failure has changed dramatically during the past 20 years, but diuretic drugs remain an essential component. Diuretics are essential despite the fact that these drugs stimulate the renin-angiotensin-aldosterone (RAA) axis and lead to adaptive responses that may be counterproductive. In this paper, new diuretic drugs and new uses of older drugs are discussed. These approaches emphasize low-dose combination therapy and may prove superior to traditional approaches that rely exclusively on loop diuretics. Such approaches aim to prevent adverse compensatory processes that appear to result from chronic diuretic treatment. These include acute and chronic increases in plasma renin activity and stimulation of the sympathetic nervous system, both of which increase afterload and may tend to increase mortality. They also include adaptive changes in nephron structure and function resulting from diuretic-induced increases in distal sodium load and diuretic-induced neurohormonal stimulation. These adaptations blunt the effectiveness of diuretic therapy. Diuretic strategies that rely on combinations of diuretics are emphasized as a method to prevent resistance. If diuretic resistance does develop, higher-dose combination regimens, continuous diuretic infusions and mechanical ultrafiltration can be used to overcome diuretic adaptations and restore diuretic efficacy. The goal of reducing the extracellular fluid volume with the least stimulation of the RAA axis and minimal changes in nephron architecture can be achieved in many patients.

Original languageEnglish (US)
Pages (from-to)132-143
Number of pages12
JournalCardiology
Volume96
Issue number3-4
DOIs
StatePublished - 2001

Fingerprint

Diuretics
Heart Failure
Therapeutics
Renin
Nephrons
Angiotensins
Aldosterone
Pharmaceutical Preparations
Essential Drugs
Sodium Potassium Chloride Symporter Inhibitors
Sympathetic Nervous System
Extracellular Fluid
Ultrafiltration
Sodium

Keywords

  • Edema
  • Loop diuretics
  • Sodium
  • Thiazides

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Diuretic therapy and resistance in congestive heart failure. / Ellison, David.

In: Cardiology, Vol. 96, No. 3-4, 2001, p. 132-143.

Research output: Contribution to journalArticle

@article{daedd64b73ca4bebac84117726739827,
title = "Diuretic therapy and resistance in congestive heart failure",
abstract = "Treatment of congestive heart failure has changed dramatically during the past 20 years, but diuretic drugs remain an essential component. Diuretics are essential despite the fact that these drugs stimulate the renin-angiotensin-aldosterone (RAA) axis and lead to adaptive responses that may be counterproductive. In this paper, new diuretic drugs and new uses of older drugs are discussed. These approaches emphasize low-dose combination therapy and may prove superior to traditional approaches that rely exclusively on loop diuretics. Such approaches aim to prevent adverse compensatory processes that appear to result from chronic diuretic treatment. These include acute and chronic increases in plasma renin activity and stimulation of the sympathetic nervous system, both of which increase afterload and may tend to increase mortality. They also include adaptive changes in nephron structure and function resulting from diuretic-induced increases in distal sodium load and diuretic-induced neurohormonal stimulation. These adaptations blunt the effectiveness of diuretic therapy. Diuretic strategies that rely on combinations of diuretics are emphasized as a method to prevent resistance. If diuretic resistance does develop, higher-dose combination regimens, continuous diuretic infusions and mechanical ultrafiltration can be used to overcome diuretic adaptations and restore diuretic efficacy. The goal of reducing the extracellular fluid volume with the least stimulation of the RAA axis and minimal changes in nephron architecture can be achieved in many patients.",
keywords = "Edema, Loop diuretics, Sodium, Thiazides",
author = "David Ellison",
year = "2001",
doi = "10.1159/000047397",
language = "English (US)",
volume = "96",
pages = "132--143",
journal = "Cardiology",
issn = "0008-6312",
publisher = "S. Karger AG",
number = "3-4",

}

TY - JOUR

T1 - Diuretic therapy and resistance in congestive heart failure

AU - Ellison, David

PY - 2001

Y1 - 2001

N2 - Treatment of congestive heart failure has changed dramatically during the past 20 years, but diuretic drugs remain an essential component. Diuretics are essential despite the fact that these drugs stimulate the renin-angiotensin-aldosterone (RAA) axis and lead to adaptive responses that may be counterproductive. In this paper, new diuretic drugs and new uses of older drugs are discussed. These approaches emphasize low-dose combination therapy and may prove superior to traditional approaches that rely exclusively on loop diuretics. Such approaches aim to prevent adverse compensatory processes that appear to result from chronic diuretic treatment. These include acute and chronic increases in plasma renin activity and stimulation of the sympathetic nervous system, both of which increase afterload and may tend to increase mortality. They also include adaptive changes in nephron structure and function resulting from diuretic-induced increases in distal sodium load and diuretic-induced neurohormonal stimulation. These adaptations blunt the effectiveness of diuretic therapy. Diuretic strategies that rely on combinations of diuretics are emphasized as a method to prevent resistance. If diuretic resistance does develop, higher-dose combination regimens, continuous diuretic infusions and mechanical ultrafiltration can be used to overcome diuretic adaptations and restore diuretic efficacy. The goal of reducing the extracellular fluid volume with the least stimulation of the RAA axis and minimal changes in nephron architecture can be achieved in many patients.

AB - Treatment of congestive heart failure has changed dramatically during the past 20 years, but diuretic drugs remain an essential component. Diuretics are essential despite the fact that these drugs stimulate the renin-angiotensin-aldosterone (RAA) axis and lead to adaptive responses that may be counterproductive. In this paper, new diuretic drugs and new uses of older drugs are discussed. These approaches emphasize low-dose combination therapy and may prove superior to traditional approaches that rely exclusively on loop diuretics. Such approaches aim to prevent adverse compensatory processes that appear to result from chronic diuretic treatment. These include acute and chronic increases in plasma renin activity and stimulation of the sympathetic nervous system, both of which increase afterload and may tend to increase mortality. They also include adaptive changes in nephron structure and function resulting from diuretic-induced increases in distal sodium load and diuretic-induced neurohormonal stimulation. These adaptations blunt the effectiveness of diuretic therapy. Diuretic strategies that rely on combinations of diuretics are emphasized as a method to prevent resistance. If diuretic resistance does develop, higher-dose combination regimens, continuous diuretic infusions and mechanical ultrafiltration can be used to overcome diuretic adaptations and restore diuretic efficacy. The goal of reducing the extracellular fluid volume with the least stimulation of the RAA axis and minimal changes in nephron architecture can be achieved in many patients.

KW - Edema

KW - Loop diuretics

KW - Sodium

KW - Thiazides

UR - http://www.scopus.com/inward/record.url?scp=0035701621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035701621&partnerID=8YFLogxK

U2 - 10.1159/000047397

DO - 10.1159/000047397

M3 - Article

C2 - 11805380

AN - SCOPUS:0035701621

VL - 96

SP - 132

EP - 143

JO - Cardiology

JF - Cardiology

SN - 0008-6312

IS - 3-4

ER -